Drug
Inz 701
Inz 701: highest development phase Phase 3, developed by BioMarin Pharmaceutical. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- BioMarin Pharmaceutical
Trials
| Drug | Phase | Indication |
|---|---|---|
| INZ-701 NCT07473973 | Phase 3 | Ectonucleotide Pyrophosphatase/phosphodiesterase1 Deficiency |
| INZ-701 NCT06283589 | Phase 1 | Calciphylaxis |
Latest
No recent events.
Follow Inz 701 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.